NCT00289809View on ClinicalTrials.gov

TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Sarcoma, Soft Tissue
Interventions
DRUG

combination of TLC D-99 and Ifosfamide

"* TLC D-99: 40 mg/m2 Day 1 every 3 weeks;~* Ifosfamide: 3000 mg/m2 Day 1, 2, 3 every 3 weeks"

Trial Locations (1)

20089

Istituto Clinico Humanitas, Rozzano

All Listed Sponsors
lead

Istituto Clinico Humanitas

OTHER

NCT00289809 - TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients | Biotech Hunter | Biotech Hunter